900
Views
6
CrossRef citations to date
0
Altmetric
Review

Engineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidem

, ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 1333-1353 | Received 18 Aug 2021, Accepted 20 Oct 2021, Published online: 15 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini & Alba Ariela Brandes. (2023) Glioblastoma treatment slowly moves toward change: novel druggable targets and translational horizons in 2022. Expert Opinion on Drug Discovery 18:3, pages 269-286.
Read now
Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto, Alicia Tosoni, Stefania Bartolini & Alba Ariela Brandes. (2023) How to treat histone 3 altered gliomas: molecular landscape and therapeutic developments. Expert Review of Clinical Pharmacology 16:1, pages 17-26.
Read now
Ruijia Liang, Cheng Wu, Shiming Liu & Wenyan Zhao. (2022) Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers. Drug Delivery 29:1, pages 1620-1630.
Read now

Articles from other publishers (3)

Vincenzo Di Nunno, Marta Aprile, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Stefania Bartolini & Enrico Franceschi. (2023) Tumor Microenvironment in Gliomas: A Treatment Hurdle or an Opportunity to Grab?. Cancers 15:4, pages 1042.
Crossref
Lidia Gatto, Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Stefania Bartolini & Alba Ariela Brandes. (2022) Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date?. Drugs 82:5, pages 491-510.
Crossref
Daniel Fowler, Callum Nattress, Alba Southern Navarrete, Marta Barisa & Jonathan Fisher. (2021) Payload Delivery: Engineering Immune Cells to Disrupt the Tumour Microenvironment. Cancers 13:23, pages 6000.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.